P1381: EARLY FULL DONOR CHIMERISM AFTER FLAMSA RIC BASED ALLOGENEIC HSCT BUT NOT PRESENCE OF MORPHOLOGICAL REMISSION ASSOCIATES WITH OUTCOMES IN R/R AML PATIENTS

• J. Ussmann,
• S. Hell,
• B. Schetschorke,
• G. Friedrich,
• C. Pfrepper,
• S. Schwind,
• M. Jentzsch,
• V. Vucinic,
• M. Herling,
• U. Platzbecker,
• G.-N. Franke

Affiliations

J. Ussmann

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

S. Hell

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

B. Schetschorke

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

G. Friedrich

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

C. Pfrepper

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

S. Schwind

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

M. Jentzsch

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

V. Vucinic

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

M. Herling

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

U. Platzbecker

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

G.-N. Franke

1 Medical Department I, Hematology, cellular therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany